Most vasectomy patients fail to comply with follow-up

Article

One-fourth of men who undergo vasectomies forego having their semen tested to determine the procedure?s effectiveness, according to a Cleveland Clinic study.

One-fourth of men who undergo vasectomies forego having their semen tested to determine the procedure’s effectiveness, according to a Cleveland Clinic study. Of 436 men who participated in the study, only 21% complied with post-vasectomy instructions, which included submitting two consecutive semen samples declared free of sperm.

“Our results show that only three-quarters of the men in this study showed up for their 8-week sperm test, which means that a quarter of them had no idea whether the procedure was successful or if their partner could become pregnant,” said lead author Nivedita Dhar, MD. “Without proper follow-up, it’s impossible to assess the true vasectomy failure rate, despite careful counseling and physician recommendations.”

The team found that, of 327 men who returned for follow-up testing at 8 weeks, 25% were producing sperm, three men were producing active sperm, and one man was diagnosed with a failed vasectomy. At 12 weeks, 65 of the 80 men were given the all-clear. Eight men were still producing motile sperm 6 months after undergoing their procedures, whereas at 10 months, semen samples for all but the vasectomy failure were reported as clear.

These findings are consistent with previous research addressing non-compliance among vasectomy patients, according to study director J. Stephen Jones, MD, and suggested that compliance could be improved by recommending one follow-up test at 12 weeks, with further follow-ups if sperm is present.

Results were reported in the British Journal of Urology International (2006; 97:773-6).

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.